International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels
Catterall, W. A.; Perez-Reyes, E.; Snutch, T. P.; Striessnig, J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels Pharmacol. Rev. 2005, 57, 411-425
Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle
Fleckenstein, A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle Annu. Rev. Pharmacol. Toxicol. 1977, 17, 149-166
Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms
Sinnegger-Brauns, M. J.; Huber, I. G.; Koschak, A.; Wild, C.; Obermair, G. J.; Einzinger, U.; Hoda, J. C.; Sartori, S. B.; Striessnig, J. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms Mol. Pharmacol. 2009, 75, 407-414
1,4-Dihydropyridine Scaffold in Medicinal Chemistry, the Story so Far and Perspectives. Part 1: Action in Ion Channels and GPCRs
Ioan, P.; Carosati, E.; Micucci, M.; Cruciani, G.; Broccatelli, F.; Zhorov, B. S.; Chiarini, A.; Budriesi, R. 1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far and Perspectives. Part 1: Action in Ion Channels and GPCRs Curr. Med. Chem. 2011, 18, 4901-4922
1,4-Dihydropyridine Scaffold in Medicinal Chemistry, the Story so Far and Perspectives. Part 2: Action in Other Targets and Antitargets
Carosati, E.; Ioan, P.; Micucci, M.; Broccatelli, F.; Cruciani, G.; Zhorov, B. S.; Chiarini, A.; Budriesi, R. 1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far and Perspectives. Part 2: Action in Other Targets and Antitargets Curr. Med. Chem. 2012, 19, 4306-4323
6-Pyridinylimidazo[2,1- b ]thiazoles and Thiazolines as Potential Cardiotonic Agents
Andreani, A.; Rambaldi, M.; Andreani, F.; Bossa, R.; Galatulas, I. 6-Pyridinylimidazo[2,1- b ]thiazoles and Thiazolines as Potential Cardiotonic Agents Eur. J. Med. Chem. 1985, 20, 93-94
Synthesis and Antitumor Activity of Guanylhydrazones from 6-(2,4-Dichloro-5-nitrophenyl)imidazo[2,1- b ]thiazoles and 6-Pyridilimidazo[2, 1- b ]thiazoles
Andreani, A.; Burnelli, S.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Farruggia, G.; Stefanelli, C.; Masotti, L.; Kunkel, M. W. Synthesis and Antitumor Activity of Guanylhydrazones from 6-(2,4-Dichloro-5-nitrophenyl)imidazo[2,1- b ]thiazoles and 6-Pyridilimidazo[2, 1- b ]thiazoles J. Med. Chem. 2006, 49, 7897-7901
New Antitumor Imidazo[2,1- b ]thiazole Guanylhydrazones and Analogues
Andreani, A.; Burnelli, S.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Calonghi, N.; Cappadone, C.; Farruggia, G.; Zini, M.; Stefanelli, C.; Masotti, L.; Radin, N. S.; Shoemaker, R. H. New Antitumor Imidazo[2,1- b ]thiazole Guanylhydrazones and Analogues J. Med. Chem. 2008, 51, 809-816
Synthesis and cardiotonic activity of 2,5-dimethoxyphenylimidazo[2,1- b ]thiazoles
Andreani, A.; Rambaldi, M.; Locatelli, A.; Bossa, R.; Galatulas, I.; Ninci, M. Synthesis and cardiotonic activity of 2,5-dimethoxyphenylimidazo[2,1- b ]thiazoles Eur. J. Med. Chem. 1992, 27, 431-433
Cystic Fibrosis: A New Target for 4-Imidazo[2,1- b ]thiazole-1,4-DHPs
Budriesi, R.; Ioan, P.; Leoni, A.; Pedemonte, N.; Locatelli, A.; Micucci, M.; Chiarini, A.; Galietta, L. J. Cystic Fibrosis: A New Target for 4-Imidazo[2,1- b ]thiazole-1,4-DHPs J. Med. Chem. 2011, 54, 3885-3094
Motulsky, H.; Christopoulos, A. Fitting Models to Biological Data Using Linear and Nonlinear Regression, 2003, www.graphpad.com. Accessed on 1/12/2011.
Haloperidol moderately inhibits cardiovascular L-type calcium current
Tarabová, B.; Nováková, M.; Lacinová, L. Haloperidol moderately inhibits cardiovascular L-type calcium current Gen. Physiol. Biophys. 2009, 28 (3) 249-529
UCSF Chimera-a visualization system for exploratory research and analysis
Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF Chimera-a visualization system for exploratory research and analysis J. Comput. Chem. 2004, 25, 1605-1612
Sampling protein motion and solvent effect during ligand binding
Limongelli, V.; Marinelli, L.; Cosconati, S.; La Motta, C.; Sartini, S.; Mugnaini, L.; Da Settimo, F.; Novellino, E.; Parrinello, M. Sampling protein motion and solvent effect during ligand binding Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 1467-1472
Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition
Limongelli, V.; Bonomi, M.; Marinelli, L.; Gervasio, F. L.; Cavalli, A.; Novellino, E.; Parrinello, M. Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 5411-5416
Identification of Glycogen Synthase Kinase-3 Inhibitors with a Selective Sting for Glycogen Synthase Kinase-3α
Lo Monte, F.; Kramer, T.; Gu, J.; Anumala, U. R.; Marinelli, L.; La Pietra, V.; Novellino, E.; Franco, B.; Demedts, D.; Van Leuven, F.; Fuertes, A.; Dominguez, J. M.; Plotkin, B.; Eldar-Finkelman, H.; Schmidt, B. Identification of Glycogen Synthase Kinase-3 Inhibitors with a Selective Sting for Glycogen Synthase Kinase-3α J. Med. Chem. 2012, 55, 4407-4424